HumanFirst @GoHumanFirst
HumanFirst is now an ICON plc company. This X account is no longer active or monitored. Please follow @iconplc for updates. iconplc.com/solutions/outc… Joined April 2017-
Tweets1K
-
Followers1K
-
Following246
-
Likes3K
2/2 We are thrilled that what we built at HumanFirst will reach more sponsors and help countless more patients. We are proud to shut this X account with such positive news. Please follow @ICONplc to see what's next for the Atlas platform & Outcome Measures. Thank you!
1/2 Big news: Our Atlas platform is now part of @ICONplc Outcome Measures, a set of capabilities to conduct more patient-centered #clinicaltrials. Learn more about Outcome Measures & contact ICON for a demo today! iconplc.com/solutions/outc…
Big News - @HumanFirst is now part of ICON, the world's leading clinical research organization! Follow @ICONplc for updates, news and more
✅ close M&A transaction ✅ move to ireland ✅ dye hair copper
What role should industry and academia play in changing how our devices monitor us? @mariojoze speaks with @AndreaCoravos and @Idasim #STATBreakthrough
@statnews @MelissaCHanna @joinmahmee @iamKSealsAllers @IrthApp @SimmoneTaitt @poppyseedhealth @ushamcfarling Can Wearables Still Upend Medicine? * Andy Coravos @AndreaCoravos @GoHumanFirst * @Idasim @UCSF Moderated by Mario Aguilar @mariojoze @statnews Your watch might tell you took a 1000 steps, but how correct is that? And is it clinically relevant? #STATBreakthrough
Passive collection of data can be powerful because patients do not like to fill out questionnaires. But wearables can create anxiety as well. A wearable is sort of an intervention. Clinicians need to learn how to use and interpret the data. #STATBreakthrough
On the wearables panel with @mariojoze, @AndreaCoravos is killing it with not only her clear explanations of clinical trials and FDA regs, but also by slipping in an Oxford English Dictionary reference (I stan!) On the power of wearables in clinical trials: #STATBreakthrough
Great to hear @AndreaCoravos bring such broad depth of experience and deep insight from @Idasim
What role should industry and academia play in changing how our devices monitor us? @Idasim @AndreaCoravos @GoHumanFirst @mariojoze #STATBreakthrough
What role should industry and academia play in changing how our devices monitor us? @mariojoze speaks with @AndreaCoravos and @Idasim #STATBreakthrough
What role should industry and academia play in changing how our devices monitor us? @Idasim @AndreaCoravos @GoHumanFirst @mariojoze #STATBreakthrough
The next #RegSci Forum, on May 7th, will feature guest speaker @AndreaCoravos on "From RegSci Classroom to Corporate Acquisition: The Story of HumanFirst". Register Here: rb.gy/2xs5yt
Despite differences in tools used as endpoints in #clinicaltrials, this paper proposes that there is enough alignment in the way COAs are categorized to build a single framework to evaluate across both actively-collecting & passively-monitoring tools. nature.com/articles/s4174…
How did we grow HumanFirst to a point where @ICONplc took an interest in our products + people? Hard work, luck, and clear Tours of Duty. TODs help startup employees define roles & goals despite the challenge of wearing multiple hats @WhatMattersOKRs whatmatters.com/articles/creat…
Check out this podcast episode with our @ICONplc colleague Gilyana Borlikova, who was nominated as a Women in AI Person of the Year for her work in developing AI solutions for clinical trials! @AIAwardsIrl aiireland.ie/2024/02/29/e13…
Deserved congrats to super smart @AndreaCoravos founder/CEO of Lux family co @GoHumanFirst
Seven years ago when we started @GoHumanFirst, we had a vision to unlock better research for all humans, faster. Today, I’m thrilled to share that we sold the company to @ICONplc (NASDAQ: ICLR), a global leader in drug development with 90 locations in 45 countries.
Huge congrats to @AndreaCoravos and the whole @GoHumanFirst team! It's been a joy and an honor to be along for the ride 👏
You might have heard the big news through the grapevine: @ICONplc (NASDAQ: ICLR) has officially acquired @GoHumanFirst. Big thank you to @mariojoze at @statnews for his clear writing & why this transaction is key to accelerate patient-centered research statnews.com/2024/02/29/ico…
Congratulations to @AndreaCoravos and @GoHumanFirst! Incredible to watch her, her vision, and her company grow over the years. Thrilled for your next chapter, @AndreaCoravos!
Seven years ago when we started @GoHumanFirst, we had a vision to unlock better research for all humans, faster. Today, I’m thrilled to share that we sold the company to @ICONplc (NASDAQ: ICLR), a global leader in drug development with 90 locations in 45 countries.
So pumped for you Andy. What a journey!! Let’s go!
Seven years ago when we started @GoHumanFirst, we had a vision to unlock better research for all humans, faster. Today, I’m thrilled to share that we sold the company to @ICONplc (NASDAQ: ICLR), a global leader in drug development with 90 locations in 45 countries.
You might like
